Your browser doesn't support javascript.
loading
Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.
Delaloye, Julie; Filali-Mouhim, Abdelali; Cameron, Mark J; Haddad, Elias K; Harari, Alexandre; Goulet, Jean-Pierre; Gomez, Carmen E; Perdiguero, Beatriz; Esteban, Mariano; Pantaleo, Giuseppe; Roger, Thierry; Sékaly, Rafick-Pierre; Calandra, Thierry.
Afiliación
  • Delaloye J; Infectious Diseases Service, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, Lausanne, Switzerland.
  • Filali-Mouhim A; Vaccine and Gene Therapy Institute, Port St. Lucie, Florida, USA.
  • Cameron MJ; Vaccine and Gene Therapy Institute, Port St. Lucie, Florida, USA.
  • Haddad EK; Vaccine and Gene Therapy Institute, Port St. Lucie, Florida, USA.
  • Harari A; Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, Lausanne, Switzerland.
  • Goulet JP; Vaccine and Gene Therapy Institute, Port St. Lucie, Florida, USA.
  • Gomez CE; Centro Nacional de Biotecnología, CSIC, Madrid, Spain.
  • Perdiguero B; Centro Nacional de Biotecnología, CSIC, Madrid, Spain.
  • Esteban M; Centro Nacional de Biotecnología, CSIC, Madrid, Spain.
  • Pantaleo G; Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, Lausanne, Switzerland.
  • Roger T; Infectious Diseases Service, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, Lausanne, Switzerland.
  • Sékaly RP; Vaccine and Gene Therapy Institute, Port St. Lucie, Florida, USA.
  • Calandra T; Infectious Diseases Service, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, Lausanne, Switzerland Thierry.Calandra@chuv.ch.
J Virol ; 89(7): 3819-32, 2015 Apr.
Article en En | MEDLINE | ID: mdl-25609807

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interferón Tipo I / Interleucina-1 / Vacunas contra el SIDA / Vectores Genéticos Límite: Humans Idioma: En Revista: J Virol Año: 2015 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interferón Tipo I / Interleucina-1 / Vacunas contra el SIDA / Vectores Genéticos Límite: Humans Idioma: En Revista: J Virol Año: 2015 Tipo del documento: Article País de afiliación: Suiza